Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis: results from the SPARTAKUS cohort

Spinal Disorders

Associations between smoking and extra-axial manifestations and disease severity in axial spondyloarthritis: results from the BSR Biologics Register for Ankylosing Spondylitis (BSRBR-AS)

Rheumatology (Oxford).

Zhao S, Jones GT, Macfarlane GJ, Hughes DM, Dean LE, Moots RJ, Goodson NJ

doi: 10.1093/rheumatology/

Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register

Rheumatology (Oxford).

Macfarlane GJ, MacDonald RIR, Pathan E, Siebert S, Gaffney K, Choy E, Packham J, Martin KR, Haywood K, Sengupta R, Atzeni F, Jones GT

doi: 10.1093/

Further Publications Rheumatology

How do clinical and socioeconomic factors impact on work disability in early axial spondyloarthritis? Five-year data from the DESIR cohort

Rheumatology (Oxford)

Nikiphorou E, Boonen A, Fautrel B, Richette P, Landewé R, van der Heijde D, Ramiro S

doi: 10.1093/rheumatology/keab607

Further Publications Rheumatology

Association between comorbidities and disease activity in axial spondyloarthritis: results from the BSRBR-AS

Rheumatology (Oxford)

Zhao SS, Jones GT, Macfarlane GJ, Hughes DM, Moots RJ, Goodson NJ

doi: 10.1093/rheumatology/keaa768

Further Publications Rheumatology

Factors associated with remission at 5-year follow-up in recent onset axial spondyloarthritis: results from the DESIR cohort

Rheumatology (Oxford)

Pina Vegas L, Sbidian E, Wendling D, Goupille P, Ferkal S, Le Corvoisier P, Ghaleh B, Luciani A, Claudepierre P

doi: 10.1093/rheumatology/keab565

COMMENTED

Spinal Disorders

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

Lancet.

van der Heijde D, Cheng-Chung Wei J, Dougados M, Mease P, Deodhar A, Maksymowych WP, Van den Bosch F, Sieper J, Tomita T, Landewé R, Zhao F, Krishnan E, Adams DH, Pangallo B, Carlier H; COAST-V study group

doi: 10.1016/S0140-

Rheumatoid ArthritisSpinal Disorders

Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis

Arthritis Res Ther.

Jarlborg M, Courvoisier DS, Lamacchia C, Martinez Prat L, Mahler M, Bentow C, Finckh A, Gabay C, Nissen MJ, physicians of the Swiss Clinical Quality Management (SCQM) registry.

doi: 10.1186/s13075-020-02190-3.

Spinal Disorders

Do obesity and overweight influence disease activity measures in axial spondyloarthritis? A systematic review and meta-analysis

Arthritis Care Res (Hoboken).

Ortolan A, Lorenzin M, Felicetti M, Ramonda R

doi: 10.1002/acr.24416.

Psoriatic Arthritis

Editorial: Sacroiliac Joint Magnetic Resonance Imaging in the Diagnosis of Axial Spondyloarthritis: “A Tiny Bit of White on Two Consecutive Slices” May Be Objective, but Not Specific

Pfeffer MA, Claggett B, Diaz R, et al. Lixisenatide in patients with type 2 diabetes and acute coronary syndrome. N Engl J Med 2015;373:2247-2257 Full Text | Web of Science | Medline

Related content

Associations between smoking and extra-axial manifestations and disease severity in axial spondyloarthritis: results from the BSR Biologics Register for Ankylosing Spondylitis (BSRBR-AS)

Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register

How do clinical and socioeconomic factors impact on work disability in early axial spondyloarthritis? Five-year data from the DESIR cohort

Association between comorbidities and disease activity in axial spondyloarthritis: results from the BSRBR-AS

Factors associated with remission at 5-year follow-up in recent onset axial spondyloarthritis: results from the DESIR cohort

Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis

Do obesity and overweight influence disease activity measures in axial spondyloarthritis? A systematic review and meta-analysis

Editorial: Sacroiliac Joint Magnetic Resonance Imaging in the Diagnosis of Axial Spondyloarthritis: “A Tiny Bit of White on Two Consecutive Slices” May Be Objective, but Not Specific